Trial Profile
A study evaluating pharmacokinetics of abiraterone and its active metabolites in healthy male volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Apr 2017
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Apalutamide
- Indications Prostate cancer
- Focus Pharmacokinetics
- 17 Apr 2017 New trial record
- 04 Apr 2017 Results presented at The 99th Annual Meeting of the Endocrine Society